Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India

Indian Journal of Gastroenterology

Volumn 32, Issue 4, 2013, Pages 246-252

  Ghoshal, Ujjala ^a   Kumar, Sushil ^a   Jaiswal, Virendra ^a   Tripathi, Shweta ^a   Mittal, Balraj ^a   Ghoshal, Uday C ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Carcinogenesis; Gene association study; Xenobiotic

Indexed keywords

ARGININE; EPOXIDE HYDROLASE; HISTIDINE; TYROSINE; UREASE; XENOBIOTIC AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HETEROZYGOTE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR LOCALIZATION;

DNA, NEOPLASM; EPOXIDE HYDROLASES; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84879686257     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-013-0332-3     Document Type: Article

References (35)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127: 2893-917.
2. Nomura A. Stomach cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. Oxford: Oxford University Press; 1996. p. 707-24.
3. Correa P. International cancer epidemiology meetings. Cancer Epidemiol Biomarkers Prev. 1992;1: 245-7.
4. Tripathi S, Ghoshal U, Ghoshal UC, et al. Gastric carcinogenesis: possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 2008;43: 431-9.
5. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52: 6735-40.
6. Correa P. Diet modification and gastric cancer prevention. J Natl Cancer Inst Monogr. 1992: 75-8.
7. Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ. 2004: 327-49.
8. Gonzalez FZ. The role of carcinogen metabolizing enzyme polymorphism in cancer susceptibility. Reprod Toxicol. 1997;11: 397-412.
9. Omiecinski CJ, Hassett C, Hosagrahara V. Epoxide hydrolase-polymorphism and role in toxicology. Toxicol Lett. 2000;112-113: 365-70.
10. Guengerich FP, Wang P, Davidson NK. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry. 1982;21: 1698-706.
11. Fretland AJ, Omiecinski CJ. Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact. 2000;129: 41-59.
12. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B. Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol. 2008;230: 247-51.
13. Wang LD, Zheng S, Liu B, Zhou JX, Li YJ, Li JX. CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high-incidence area in north China. World J Gastroenterol. 2003;9: 1394-7.
14. Gsur A, Zidek T, Schnattinger K, et al. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer. 2003;89: 702-6.
15. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994;3: 421-8.
16. Hassett C, Robinson KB, Beck NB, Omiecinski CJ. The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics. 1994;23: 433-42.
17. de Jong DJ, van der Logt EM, van Schaik A, Roelofs HM, Peters WH, Naber TH. Genetic polymorphisms in biotransformation enzymes in Crohn's disease: association with microsomal epoxide hydrolase. Gut. 2003;52: 547-51.
18. Peters WH, van der Logt EM, Te Morsche RH, Roelofs HM, de Jong DJ, Naber TH. No genetic association between EPHX1 and Crohn's disease. Gut. 2005;54: 1659-60.
19. Ghoshal UC, Ghosh TK, Ghoshal U, Shujaatullah F, Banerjee PK, Mazumder DN. In-house rapid urease test kit and commercial kit: which is better? Indian J Gastroenterol. 1999;18: 183.
20. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer. 1999;79: 168-71.
21. Shou M, Gonzalez FJ, Gelboin HV. Stereoselective epoxidation and hydration at the K-region of polycyclic aromatic hydrocarbons by cDNA-expressed cytochromes P450 1A1, 1A2, and epoxide hydrolase. Biochemistry. 1996;35: 15807-13.
22. Brenneis C, Sisignano M, Coste O, et al. Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation. Mol Pain. 2011;7: 78.
23. Pillarisetti S, Khanna I. Targeting soluble epoxide hydrolase for inflammation and pain-an overview of pharmacology and the inhibitors. Inflamm Allergy Drug Targets. 2012;11: 143-58.
24. Sandberg M, Hassett C, Adman ET, Meijer J, Omiecinski CJ. Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem. 2000;275: 28873-81.
25. Kiran M, Chawla YK, Kaur J. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India. DNA Cell Biol. 2008;27: 687-94.
26. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 1998;58: 5291-3.
27. Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD. Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev. 2001;10: 875-82.
28. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325: 1127-31.
29. Anonymous. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet. 1993;341: 1359-62.
30. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991;302: 1302-5.
31. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325: 1132-6.
32. Tripathi S, Ghoshal U, Mittal B, Chourasia D, Kumar S, Ghoshal UC. Association between gastric mucosal glutathione-S-transferase activity, glutathione-S-transferase gene polymorphisms and Helicobacter pylori infection in gastric cancer. Indian J Gastroenterol. 2011;30: 257-63.
33. Singh K, Ghoshal UC. Causal role of Helicobacter pylori in gastric cancer: an Asian enigma. World J Gastroenterol. 2006;12: 1346-51.
34. Ghoshal UC, Chaturvedi R, Correa P. The enigma of Helicobacter pylori infection and gastric cancer. Indian J Gastroenterol. 2010;29: 95-100.
35. Cuthbert AP, Fisher SA, Lewis CM, Mathew CG, Sanderson J, Forbes A. Genetic association between EPHX1 and Crohn's disease: population stratification, genotyping error, or random chance? Gut. 2004;53: 1386.